Induced Pluripotent Stem Cells Generated Without Viral Integration
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome-integrating viruses. We generated mouse induced pluripotent stem (iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c-Myc. These adenoviral iPS (adeno-iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient-specific stem cells and for comparing embryonic stem cells and iPS cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming [24,25,26,27,28].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Self-citationReprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
Dissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,480
Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., & Jaenisch, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801677105 · Cited by 1,216
Research works printed but not linked: 1
- S. Eminli J. Utikal K. Arnold R. Jaenisch K. Hochedlinger Stem Cells published online 17June2008 in press.
Cited by
Items 901–1,000 of 1,002
Stem Cells Therapy in Diabetes Mellitus
Yang, X. (2014) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000199 · Cited by 14
Effenberg, A., Stanslowsky, N., Klein, A., Wesemann, M., Haase, A., Martin, U., Dengler, R., Grothe, C., Ratzka, A., & Wegner, F. (2015) · Cell Transplantation · doi:10.3727/096368914x685591 · Cited by 14
Live Imaging Mitochondrial Transport in Neurons
Course, M. M., Hsieh, C.-H., Tsai, P.-I., Codding-Bui, J. A., Shaltouki, A., & Wang, X. (2017) · Neuromethods · doi:10.1007/978-1-4939-6890-9_3 · Cited by 14
Gene Delivery Techniques for Adult Stem Cell-Based Regenerative Therapy
Seo, S.-J., Kim, T.-H., Choi, S., Park, J.-H., Wall, I. B., & Kim, H. (2013) · Nanomedicine · doi:10.2217/nnm.13.165 · Cited by 14
Application of induced pluripotent stem cells in the conservation of endangered animals
Lou, J., Li, W., Chen, P., Chen, H., Shakoor, A., Chen, Y., Hua, J., Wang, Y., & Zhang, S. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04392-5 · Cited by 14
The iPS Technique Provides Hope for Parkinson’s Disease Treatment
Xu, L., Tan, Y., Ding, J., & Chen, S. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9145-2 · Cited by 14
Okita, K. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32834252a2 · Cited by 14
Zaldumbide, A., Carlotti, F., Gonçalves, M. A. F. V., Knaän‐Shanzer, S., Cramer, S. J., Roep, B. O., Wiertz, E. J. H. J., & Hoeben, R. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048093 · Cited by 14
Generation of non-viral, transgene-free hepatocyte like cells with piggyBac transposon
Katayama, H., Yasuchika, K., Miyauchi, Y., Kojima, H., Yamaoka, R., Kawai, T., Yoshitoshi, E. Y., Ogiso, S., Kita, S., Yasuda, K., et al. (2017) · Scientific Reports · doi:10.1038/srep44498 · Cited by 14
Boheler, K. R. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-07-0507 · Cited by 14
Improving therapeutic potential of non-viral minimized DNA vectors
Arevalo-Soliz, L. M., Hardee, C. L., Fogg, J. M., Corman, N. R., Noorbakhsh, C., & Zechiedrich, L. (2020) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2020.163 · Cited by 14
SCNT versus iPSCs: proteins and small molecules in reprogramming
Han, F., Li, X., Song, D., Jiang, S., Xu, Q. J., & Zhang, Y. (2015) · The International Journal of Developmental Biology · doi:10.1387/ijdb.150042fh · Cited by 14
Clinical potentials of human pluripotent stem cells in lung diseases
Quan, Y., & Wang, D. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-15 · Cited by 14
Establishment of human induced pluripotent stem cell lines from normal fibroblast TIG-1
Kumazaki, T., Kurata, S., Matsuo, T., Mitsui, Y., & Takahashi, T. (2011) · Human Cell · doi:10.1007/s13577-011-0016-1 · Cited by 14
microRNA-based cancer cell reprogramming technology
Nishikawa, S., Ishii, H., Haraguchi, N., KANO, Y., Fukusumi, T., Ohta, K., Ozaki, M., Dewi, D. L., Sakai, D., Satoh, T., et al. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.558 · Cited by 14
Cell Reprogramming, IPS Limitations, and Overcoming Strategies in Dental Bioengineering
Ibarretxe, G., Alvarez, A. A., Cañavate, M., Hilario, E., Aurrekoetxea, M., & Unda, F. J. (2012) · Stem Cells International · doi:10.1155/2012/365932 · Cited by 14
Spermatogonial stem cells,in vivotransdifferentiation and human regenerative medicine
Simon, L., Hess, R. A., & Cooke, P. S. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712591003614731 · Cited by 14
Human Adult Testis-Derived Pluripotent Stem Cells: Revealing Plasticity from the Germline
Payne, C. J., & Braun, R. E. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.10.009 · Cited by 14
Induced Pluripotent Stem Cells: Reprogrammed without a Trace
Nelson, T. J., & Terzic, A. (2009) · Regenerative Medicine · doi:10.2217/rme.09.16 · Cited by 14
Kumar, D., Anand, T., Vijayalakshmy, K., Sharma, P., Rajendran, R., Selokar, N. L., Yadav, P., & Kumar, D. (2019) · Research in Veterinary Science · doi:10.1016/j.rvsc.2019.01.015 · Cited by 14
Somatic Cell Dedifferentiation/Reprogramming for Regenerative Medicine
Ramesh, T., Lee, S. H., Lee, C.-S., Kwon, Y., & Cho, H. (2009) · International Journal of Stem Cells · doi:10.15283/ijsc.2009.2.1.18 · Cited by 14
Steering a New Course for Stem Cell Research: NIH's Intramural Center for Regenerative Medicine
Rao, M. S., & Collins, F. S. (2011) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0032 · Cited by 14
Nissan, X., Blondel, S., & Peschanski, M. (2011) · Biochemical Society Transactions · doi:10.1042/bst20110659 · Cited by 13
A poor imitation of a natural process: A call to reconsider the iPSC engineering technique
Zhang, Y., Yao, L., Yu, X., Ou, J., Ning, H., & Liu, S. (2012) · Cell Cycle · doi:10.4161/cc.22575 · Cited by 13
Szebényi, K., Erdei, Z., Péntek, A., Sebe, A., Orbán, T. I., Sarkadi, B., & Apáti, Á. (2011) · Personalized Medicine · doi:10.2217/pme.11.19 · Cited by 13
Hartjes, K. A., Li, X., Martinez‐Fernandez, A., Roemmich, A. J., Larsen, B. T., Terzic, A., & Nelson, T. J. (2014) · Stem Cells · doi:10.1002/stem.1734 · Cited by 13
Induced Pluripotent Stem Cells: Progress and Future Perspectives in the Stem Cell World
Rezanejad, H., & Matin, M. M. (2012) · Cellular Reprogramming · doi:10.1089/cell.2012.0039 · Cited by 13
Locke, M., Ussher, J. E., Mistry, R. M., Taylor, J. A., & Dunbar, P. R. (2011) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2011.0153 · Cited by 13
Cellular Reprogramming: A New Technology Frontier in Pharmaceutical Research
Brock, A., Goh, H.-T., Yang, B., Lu, Y., Li, H., & Loh, Y. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0618-z · Cited by 13
Cell-Based Therapy for the Deficient Urinary Sphincter
Hart, M. L., Neumayer, K. M. H., Vaegler, M., Daum, L., Amend, B., Sievert, K. D., Giovanni, S. D., Kraushaar, U., Guenther, E., Stenzl, A., et al. (2013) · Current Urology Reports · doi:10.1007/s11934-013-0352-7 · Cited by 13
Gene transfer mediated by stem cell grafts to treat CNS injury
Hwang, D. H., Jeong, S. R., & Kim, B. G. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.631908 · Cited by 13
Roessler, R., Boddeke, E., & Copray, S. C. V. M. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9369-4 · Cited by 13
Moraveji, S., Attari, F., Shahverdi, A., Sepehri, H., Farrokhi, A., Hassani, S., Fonoudi, H., Aghdami, N., & Baharvand, H. (2012) · Human Reproduction · doi:10.1093/humrep/des204 · Cited by 13
Chemische Kontrolle des Schicksals und Entwicklungspotenzials von Stammzellen
Lyssiotis, C. A., Lairson, L. L., Boitano, A. E., Wurdak, H., Zhu, S., & Schultz, P. G. (2010) · Angewandte Chemie · doi:10.1002/ange.201004284 · Cited by 13
An Overview of Pluripotent Stem Cells
Bhartiya, D., Nagvenkar, P. V., Sriraman, K., & Shaikh, A. (2013) · InTech eBooks · doi:10.5772/55130 · Cited by 13
Secher, J. B., Callesen, H., Freude, K., & Hyttel, P. (2015) · Theriogenology · doi:10.1016/j.theriogenology.2015.09.017 · Cited by 13
Zhao, H., Davies, T. J., Ning, J., Chang, Y., Sachamitr, P., Sattler, S., Fairchild, P. J., & Huang, F. (2014) · Cellular Reprogramming · doi:10.1089/cell.2014.0046 · Cited by 13
Sebe, A., & Ivics, Z. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3372-3_26 · Cited by 13
Noguchi, H., Miyagi‐Shiohira, C., Nakashima, Y., Kinjo, T., Kobayashi, N., Saitoh, I., Watanabe, M., Shapiro, A. M. J., & Kin, T. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.01.011 · Cited by 13
Lach, M., Wróblewska, J. P., Augustyniak, E., Kulcenty, K. I., & Suchorska, W. M. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.02.004 · Cited by 13
Varga, E., Nemes, C., Davis, R. P., Ujhelly, O., Klincumhom, N., Polgár, Z., Muenthaisong, S., Pirity, M. K., & Dinnyés, A. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.02.006 · Cited by 13
Current Methods for Inducing Pluripotency in Somatic Cells
Tavernier, G., Mlody, B., Demeester, J., Adjaye, J., & Smedt, S. C. D. (2013) · Advanced Materials · doi:10.1002/adma.201204874 · Cited by 13
Phenotype switching through epigenetic conversion
Brevini, T., Pennarossa, G., Maffei, S., & Gandolfi, F. (2015) · Reproduction Fertility and Development · doi:10.1071/rd14246 · Cited by 13
A safer stem cell: inducing pluripotency
Clarke, L., & van der Kooy, D. (2009) · Nature Medicine · doi:10.1038/nm0909-1001 · Cited by 13
Induced pluripotent stem (iPS) cells: an up-to-the-minute review
Lau, F. H., Ahfeldt, T., Osafune, K., Akustsu, H., & Cowan, C. A. (2009) · F1000 Biology Reports · doi:10.3410/b1-84 · Cited by 12
Schott, J. W., Hoffmann, D., Maetzig, T., Müller, F.-J., Steinemann, D., Zychlinski, D., Cantz, T., Baum, C., & Schambach, A. (2014) · Gene Therapy · doi:10.1038/gt.2014.69 · Cited by 12
Tian, Z., Guo, F., Biswas, S., & Deng, W. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040594 · Cited by 12
Wong, C. J., Casper, R. F., & Rogers, I. M. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.01.018 · Cited by 12
Stem Cell Biology in Health and Disease
Dittmar, T., & Zänker, K. S. (2009) · Springer eBooks · doi:10.1007/978-90-481-3040-5 · Cited by 12
Toward in Vitro Production of Platelet from Induced Pluripotent Stem Cells
Izadi, E., Saltanatpour, Z., Liu, L., Alizadeh, A., & Hamidieh, A. A. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10366-4 · Cited by 12
Reprogramming of gastrointestinal cancer cells
Dewi, D. L., Ishii, H., Haraguchi, N., Nishikawa, S., Kano, Y., Fukusumi, T., Ohta, K., Miyazaki, S., Ozaki, M., Sakai, D., et al. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2011.02184.x · Cited by 12
Ben‐Yehudah, A., Easley, C. A., Hermann, B. P., Castro, C. A., Simerly, C. R., Orwig, K. E., Mitalipov, S. M., & Schatten, G. P. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt24 · Cited by 12
Parameswaran, S., Balasubramanian, S., Rao, M. S., & Ahmad, I. (2011) · Stem Cells · doi:10.1002/stem.655 · Cited by 12
Pluripotent State Induction in Mouse Embryonic Fibroblast Using mRNAs of Reprogramming Factors
Elsayed, A. K., Zhang, Z., Zhang, L., Liu, Z., Abbott, L. C., Zhang, Y., & Li, B. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151221840 · Cited by 12
Induced Pluripotent Stem Cells in Disease Modelling and Regeneration
Talug, B., & Keskin, Z. T. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_290 · Cited by 12
Stem Cells: A Renewable Source of Pancreatic β-Cells and Future for Diabetes Treatment
Kh, S., & Haider, K. H. (2021) · Springer eBooks · doi:10.1007/978-3-030-77052-5_12 · Cited by 12
Induced Pluripotent Stem Cells: The Dragon Awakens
Han, W., Zhao, Y., & Fu, X. (2010) · BioScience · doi:10.1525/bio.2010.60.4.6 · Cited by 12
Cardiovascular stem cells in regenerative medicine: ready for prime time?
Liu, Y., Karra, R., & Wu, S. M. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.12.003 · Cited by 12
Role of Zscan4 in secondary murine iPSC derivation mediated by protein extracts of ESC or iPSC
Kwon, Y., Paek, J. S., Cho, H., Lee, C.-S., Lee, H.-J., Park, I., Roh, T., Kang, C.-M., Yang, H., Park, Y.-B., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.031 · Cited by 12
Bhartiya, D., & Lenka, N. (2013) · InTech eBooks · doi:10.5772/45917 · Cited by 12
Pluripotent stem cell-derived neural stem cells: From basic research to applications
Otsu, M., Nakayama, T., & Inoue, N. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i5.651 · Cited by 12
Ungefroren, H., & Fändrich, F. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_29 · Cited by 12
Further Promise of Stem Cells Therapies in the Enteric Nervous System
Becker, L. S., & Mashimo, H. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.022 · Cited by 12
Strategies for future histocompatible stem cell therapy
Nehlin, J. O., & Barington, T. (2009) · Biogerontology · doi:10.1007/s10522-009-9213-7 · Cited by 11
Engineered MSCs from Patient-Specific iPS Cells
Eberle, I., Moslem, M., Henschler, R., & Cantz, T. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_156 · Cited by 11
Induced pluripotent stem cells and regenerative medicine
Chen, Y.-C., Tsai, K.-L., Hung, C.-W., Ding, D., Chen, L.-H., Chang, Y.-L., Chen, L., & Chiou, S. (2011) · Journal of Clinical Gerontology and Geriatrics · doi:10.1016/j.jcgg.2010.12.003 · Cited by 11
Cell and tissue reprogramming: Unlocking a new era in medical drug discovery
Sen, C. K., Friday, A. J., & Roy, S. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100077 · Cited by 11
Modelling neurodegenerative diseases in vitro: Recent advances in 3D iPSC technologies
Siney, E. J., Kurbatskaya, K., Chatterjee, S., Prasannan, P., Mudher, A. K., & Willaime‐Morawek, S. (2018) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2018.1.1 · Cited by 11
Induced pluripotent stem cell technology and aquatic animal species
Temkin, A. M., & Spyropoulos, D. D. (2014) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2014.02.003 · Cited by 11
Pluripotent stem cell-based cell therapies: Current applications and future prospects
Wang, G., Heimendinger, P., Ramelmeier, R. A., & Wang, W. (2022) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2022.100390 · Cited by 11
The Art of Human Induced Pluripotent Stem Cells: The Past, the Present and the Future
Zhang, X., Angeles, A. D. L., & Zhang, J. (2010) · The Open Stem Cell Journal · doi:10.2174/1876893801002010002 · Cited by 11
Dolatshad, H., Tatwavedi, D., Ahmed, D., Tegethoff, J. F., Boultwood, J., & Pellagatti, A. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.10.001 · Cited by 11
Cellular Models: HD Patient-Derived Pluripotent Stem Cells
Smith-Geater, C., Hernandez, S. J., Thompson, L. M., & Mattis, V. B. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7825-0_4 · Cited by 11
Yu, Y., Li, L., Lin, S., & Hu, J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02685-z · Cited by 11
Nogueira, I. P. M., Costa, G. M. J., & Lacerda, S. M. D. S. N. (2024) · Animals · doi:10.3390/ani14020220 · Cited by 11
Advances in Human Induced Pluripotent Stem Cell-Derived Hepatocytes for Use in Toxicity Testing
Wills, L. R., & Rajagopalan, P. (2019) · Annals of Biomedical Engineering · doi:10.1007/s10439-019-02331-z · Cited by 11
Human Pluripotent Stem Cells for Genetic Disease Modeling and Drug Screening
Gauthier, M., Maury, Y., Peschanski, M., & Martinat, C. (2011) · Regenerative Medicine · doi:10.2217/rme.11.46 · Cited by 11
Wong, G., & Chiu, A. T. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.05.019 · Cited by 11
Adult stem cells in the treatment of acute myocardial infarction
Sharif, F., Bartúnek, J., & Vanderheyden, M. (2010) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22620 · Cited by 11
Synthetic mRNA Reprogramming of Human Fibroblast Cells
Liu, J., & Verma, P. J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2848-4_2 · Cited by 11
Hao, J., Sawyer, D. B., Hatzopoulos, A. K., & Hong, C. C. (2011) · Recent Patents on Regenerative Medicine · doi:10.2174/2210296511101030263 · Cited by 11
Yang, W. C., Welsh, J. P., Lee, J. L., Cooke, J. P., & Swartz, J. R. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2011.06.017 · Cited by 11
Pluripotent Stem Cell Biology - Advances in Mechanisms, Methods and Models
Atwood, C., & Meethal, S. V. (2014) · InTech eBooks · doi:10.5772/57025 · Cited by 11
Red Blood Cells from Pluripotent Stem Cells for use in Transfusion
Mountford, J. C., Olivier, E. N., Jordanides, N. E., Sousa, P. A. D., & Turner, M. L. (2010) · Regenerative Medicine · doi:10.2217/rme.10.22 · Cited by 11
Feng, G., Cui, J., Zheng, Y.-Z., Han, Z., Xu, Y., & Li, Z. (2012) · PubMed · doi:10.14670/hh-27.827 · Cited by 11
Reprogramming of two somatic nuclei in the same ooplasm leads to pluripotent embryonic stem cells
Pfeiffer, M. J., Esteves, T. C., Balbach, S. T., Araúzo-Bravo, M. J., Stehling, M., Jauch, A. S., Houghton, F. D., Schwarzer, C., & Boiani, M. (2013) · Stem Cells · doi:10.1002/stem.1497 · Cited by 11
Induced Pluripotent Stem Cells in Regenerative Medicine
Pane, L. S., My, I., & Moretti, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-27610-6_3 · Cited by 10
Deciphering Rett Syndrome with Mouse Genetics, Epigenomics, and Human Neurons
Tao, J., Wu, H., & Sun, Y. E. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)89007-7 · Cited by 10
Diecke, S., Lisowski, L., Kooreman, N. G., & Wu, J. C. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1047-2_1 · Cited by 10
Kramer, N., Rosner, M., Kovačic, B., & Hengstschläger, M. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1763-2 · Cited by 10
Bao, Q., Tay, N. L., Lim, C. Y., Chua, D. H. H., Kee, S. K., Choolani, M. A., Loh, Y., Ng, S. C., & Chai, C. (2024) · Scientific Reports · doi:10.1038/s41598-023-50510-9 · Cited by 10
From embryonic stem cells to iPS – an ethical perspective
Suaudeau, J. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2010.00723.x · Cited by 10
Pluripotent Stem Cell-Derived Pancreatic β-Cells: Potential for Regenerative Medicine in Diabetes
Kao, D.-I., & Chen, S. (2012) · Regenerative Medicine · doi:10.2217/rme.12.27 · Cited by 10
Cui, G., Xu, Y., Cao, S., & Shi, K. (2022) · Molecular Reproduction and Development · doi:10.1002/mrd.23559 · Cited by 10
Great Expectations: Induced pluripotent stem cell technologies in neurodevelopmental impairments
Zhang, X., Li, Z., Liu, Y., & Gai, Z. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.51842 · Cited by 10
Jeong, J., Kim, T. H., Kim, M., Jung, Y. K., Kim, K. S., Shim, S., Jang, H., Jang, W. I., Lee, S. B., & Choi, D. (2022) · Biology · doi:10.3390/biology11040493 · Cited by 10
iPS cells generation: an overview of techniques and methods
Telpalo-Carpio, S. A., Aguilar‐Yáñez, J. M., González‐Garza, M. T., Cruz-Vega, D., & Moreno-Cuevas, J. E. (2013) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.0901002 · Cited by 10
Recent advances in stem cell research for the treatment of diabetes
Noguchi, H. (2009) · World Journal of Stem Cells · doi:10.4252/wjsc.v1.i1.36 · Cited by 10
Ding, Q., Wang, X., Li, T. S., Li, Y. F., Li, W. Y., Gao, J. H., Liu, Y. R., & Zhuang, W. (2024) · Stem Cells International · doi:10.1155/2024/2741681 · Cited by 10
Pan, C., Jia, W., Lu, B., & Bishop, C. E. (2014) · Gene · doi:10.1016/j.gene.2014.11.061 · Cited by 10
Metadata
- Authors
- Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- Hochedlinger, Konrad
- Venue
- Science
- Published
- 2008-11-07
- Volume
- 322
- Issue
- 5903
- Pages
- 945-949
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3987909
- OpenAlex
- W2050689355
- Cited by
- 1,683
- References
- 29
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 33 · 2023: 22 · 2022: 32 · 2021: 55 · 2020: 50 · 2019: 38 · 2018: 63 · 2017: 63 · 2016: 104 · 2015: 105 · 2014: 139 · 2013: 161 · 2012: 185
- FWCI
- 82.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1dp2od003266-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- induced pluripotent stem cells, Oct4, SOX2, KLF4, c-Myc, somatic cell reprogramming, DNA demethylation, teratoma, chimeric mice, fibroblasts, hepatocytes, insertional mutagenesis, patient-derived stem cells, embryonic stem cells
- MeSH terms
- Kruppel-Like Factor 4, Adenoviridae, Animals, Cell Differentiation, Cell Line, Chimera, Cloning, Molecular, Female, Fibroblasts, Genetic Vectors, Liver, Male, Teratoma, Genes, myc, Proto-Oncogene Proteins c-myc, Mice, SCID, Virus Integration, Transgenes, Hepatocytes, Pluripotent Stem Cells, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.